Live
FierceBiotechTakeda pivotal trial win improves convenience for PID patients relative to HyQviaEndpoints NewsCelcuity breast cancer win; Odyssey plans $205M IPO; Latus Bio extends Series AFierceBiotechWindward catches $165M breeze to fuel long-acting TSLP ambitionsEndpoints NewsBiotech has a new startup model: Small team, big check and Chinese assetsThermo FisherThermo Fisher Scientific Introduces Gibco CTS DynaXS Single Use Bioreactor - Contract PharmaPharmaVoiceProtein degraders gain speed as Arvinas scores landmark approvalEndpoints NewsWindward Bio gets $165M to take China-derived drug into Phase 3 asthma trialBioWorldBeijing Danatlas Pharmaceutical Technology prepares new PARG inhibitorsBioWorldShanghai Pharmaceuticals reports new FR-α-targeting ADCsBioWorldSanyou Biopharmaceuticals discloses TROP2-targeting ADCsBioWorldHoliday noticeBioWorldBeone eyes Huahui Health’s trispecific HH-160 with $2B option deal

Archive

Total 10022
Page 283 / 557
Query --